Status:
COMPLETED
Blood-pressure Measuring in Patients Carrying a Left Ventricular Assist Device
Lead Sponsor:
Insel Gruppe AG, University Hospital Bern
Conditions:
Left Ventricular Assist Device
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
To prove the novel device is able to reliably detect pulsatility in patients with CF-VADs and to analyze whether pre-programmed intrinsic pulsatility of the 3rd generation CF-VADs can also be picked u...
Detailed Description
The number of patients supported by left ventricular assist device (LVAD) is increasing as durable mechanical support has become widely available for end stage heart failure as destination therapy and...
Eligibility Criteria
Inclusion
- Patients carrying one of the two third generation CF-VADS (Heartware HVAD, Heartmate 3)
- Patients \>18y
- Good understanding of written and oral German
- Signed informed consent
- Scheduled for routine outpatient appointment.
Exclusion
- In the population of the outpatient clinic's CV-LVAD patients no known exclusion criteria exists
Key Trial Info
Start Date :
February 27 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2020
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03458988
Start Date
February 27 2018
End Date
December 31 2020
Last Update
November 23 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Bern
Bern, Switzerland, 3010